🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#AntibodyDrugConjugates Show Unique Advantage in Breast Cancer 👇 Targeted Oncology discuss #ADCs in multiple types of breast cancer, and when to use these drugs in sequence. Read the article below 👇 targetedonc.com/view/antibody-…

Happy Thanksgiving! 🇺🇸🎆

The #antibodydrugconjugate renaissance 👇 nature discuss how antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Read more below 👇 nature.com/articles/d4247…

❔A urine test to detect some of the first signs of lung cancer❔ Research funded by Cancer Research UK has been developing just that! 👆 Click below to read our article on this new development.

Do you know your ADCs? Antibody drug conjugates are a group of cancer therapies reshaping the world of cancer treatment, by directly targeting the cancerous cells within the tumour. Watch the full video here: youtube.com/watch?v=0buzP4…

Happy Holidays to all of our employees, consultants, suppliers and followers 🌟 We wish you a happy and healthy 2025!

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic breast cancer who had progressed on multiple line of therapy. #bcsm | UCSF Health hubs.li/Q03383cc0

A great article on how #Antibodydrugconjugates are being used in the neuro-oncology field. Read more below 👇

Today on #WorldCancerDay we’d like to highlight our portfolio companies working to research, treat & fight cancer. We are proud to support a range of innovative clinical-stage companies spanning various modalities including: Artios, Iksuda Therapeutics, Microbiotica Ltd & Storm Therapeutics

February 4th is #WorldCancerDay, a day for encouraging awareness and prevention of cancer. Remember: early diagnosis saves lives. Thank you to our team and all the scientists out there working hard developing new cancer treatments

It's less than a month to go now before World ADC London 2025. Iksuda will be attending each day so if you see us then come say hello to the team 👋 Robert Lutz and Jutta Deckert will also be speaking so make sure you don't miss it!

We'll be off to Boston later this month as Toni Pringle is attending the 4th Annual Novel Conjugates Summit! We hope to see you there, if you see us come say hello 👋

Research, innovation & ADCs are of course our top priorities at Iksuda... but that doesn't mean we aren't passionate about pancakes too! A happy pancake day from Iksuda to everyone celebrating!

It's day 2 of #WorldADC 2025 and it's been a fantastic conference so far. We've attended a lot of interesting talks and met a lot of interesting people. 🤝 We'll still be here tomorrow, so if you see any of the Iksuda team then don't be shy - say hello! 👋

March 8th is #InternationalWomensDay so we're celebrating the women who've helped shape the world we live in💜 We're also celebrating women who are shaping the world of tomorrow, like our team here at Iksuda!💪 Here's to all the amazing women in the world of science and beyond!

We are excited to present three posters at the American Association for Cancer Research (AACR) Annual Meeting in Chicago next week! Click the link below to learn more: iksuda.com/news-views/iks…

We're very excited to be attending the LSX World Congress in London this week! We hope to see you there too, if you see us come say hello 👋

Iksuda are proud to announce our very first patient dosed in a phase 1 trial evaluating IKS03! See below for more details 👇 iksuda.com/news-views/iks…

📢Our Executive Director, Development Leadership, Jenny Thirlway will be attending the 18th International Conference on Malignant Lymphoma (ICML) this week. We hope to see you there! 👋 #18ICML

We're happy to announce Iksuda Therapeutics have received FDA IND clearance for IKS014! See below for more details 👇 iksuda.com/news-views/iks…